The purpose of this research review was to examine current scientific literature on COVID-19 vaccine-induced side effects in older adults. We reviewed studies focusing on side effects categorized into cardiologic, immunologic, neurologic, and ocular groups. Cardiologic side effects included myocarditis, pericarditis, and myocardial infarction. Immunologic conditions examined were anaphylaxis and vaccine-induced immune thrombotic thrombocytopenia. Neurologic side effects included Guillain-Barré syndrome and Bell’s Palsy. Ocular side effects covered ocular swelling, submacular hemorrhage, and corneal graft rejection after keratoplasty and Descemet membrane endothelial keratoplasty. Additionally, less common side effects in older adults were reviewed but found to be statistically rare. Overall, COVID-19 vaccine-induced side effects in elderly populations were rare. We concluded that the vaccine’s efficacy in preventing excess deaths due to COVID-19 is significant, and the risk of these rare side effects does not justify foregoing vaccination in at-risk individuals. Patients at higher risk for these side effects should be informed, and additional considerations should be made by their treating physician. This review aims to increase awareness of rare vaccine-induced side effects to encourage further studies, enhancing understanding of their etiology and prevalence in at-risk older adult populations.
References
[1]
Razzaque, M.S. (2024) Can Adverse Cardiac Events of the COVID-19 Vaccine Exacerbate Preexisting Diseases? Expert Review of Anti-infective Therapy, 22, 131-137. https://doi.org/10.1080/14787210.2024.2311837
[2]
Li, Y., Chi, W., Su, J., Ferrall, L., Hung, C. and Wu, T.-C. (2020) Coronavirus Vaccine Development: From SARS and MERS to Covid-19. Journal of Biomedical Science, 27, Article No. 104. https://doi.org/10.1186/s12929-020-00695-2
[3]
Mirtaleb, M.S., Falak, R., Heshmatnia, J., Bakhshandeh, B., Taheri, R.A., Soleimanjahi, H., et al. (2023) An Insight Overview on COVID-19 mRNA Vaccines: Advantageous, Pharmacology, Mechanism of Action, and Prospective Considerations. International Immunopharmacology, 117, Article 109934. https://doi.org/10.1016/j.intimp.2023.109934
[4]
Parums, D.V. (2021) Editorial: First Full Regulatory Approval of a COVID-19 Vaccine, the BNT162b2 Pfizer-BioNTech Vaccine, and the Real-World Implications for Public Health Policy. Medical Science Monitor, 27, e934625. https://doi.org/10.12659/msm.934625
[5]
van den Ouweland, F., Charpentier, N., Türeci, Ö., Rizzi, R., Mensa, F.J., Lindemann, C., et al. (2024) Safety and Reactogenicity of the BNT162b2 COVID-19 Vaccine: Development, Post-Marketing Surveillance, and Real-World Data. Human Vaccines & Immunotherapeutics, 20, Article 2315659. https://doi.org/10.1080/21645515.2024.2315659
[6]
Tseng, H.F., Ackerson, B.K., Sy, L.S., Tubert, J.E., Luo, Y., Qiu, S., et al. (2023) mRNA-1273 Bivalent (Original and Omicron) COVID-19 Vaccine Effectiveness against COVID-19 Outcomes in the United States. Nature Communications, 14, Article No. 5851. https://doi.org/10.1038/s41467-023-41537-7
[7]
Murthy, B.P., Sterrett, N., Weller, D., Zell, E., Reynolds, L., Toblin, R.L., et al. (2021) Disparities in COVID-19 Vaccination Coverage between Urban and Rural Counties —United States, December 14, 2020–April 10, 2021. Morbidity and Mortality Weekly Report, 70, 759-764. https://doi.org/10.15585/mmwr.mm7020e3
[8]
Lee, C., Kuo, H., Liu, Y., Chuang, J. and Chou, J. (2024) Population-Based Evaluation of Vaccine Effectiveness against SARS-CoV-2 Infection, Severe Illness, and Death, Taiwan Region. Emerging Infectious Diseases, 30, 478-489. https://doi.org/10.3201/eid3003.230893
[9]
Akrami, M., Hosamirudsari, H., Faraji, N., Behnush, B., Goudarzi, F., Hesari, E., et al. (2023) Sputnik V Vaccine-Related Complications and Its Impression on Inflammatory Biomarkers in Healthcare Providers. Indian Journal of Medical Microbiology, 43, 79-84. https://doi.org/10.1016/j.ijmmb.2022.10.012
[10]
Cross, S., Rho, Y., Reddy, H., Pepperrell, T., Rodgers, F., Osborne, R., et al. (2021) Who Funded the Research behind the Oxford-Astrazeneca COVID-19 Vaccine? BMJ Global Health, 6, e007321. https://doi.org/10.1136/bmjgh-2021-007321
[11]
Zafar, U., Zafar, H., Ahmed, M.S. and Khattak, M. (2022) Link between COVID-19 Vaccines and Myocardial Infarction. World Journal of Clinical Cases, 10, 10109-10119. https://doi.org/10.12998/wjcc.v10.i28.10109
[12]
Wagner, A.L., Zhang, F., Kerekes, S., Shih, S. and Zhao, L. (2023) COVID-19 Vaccination Preferences during a Pause in Johnson & Johnson Vaccine Administration. Vaccine: X, 15, Article 100373. https://doi.org/10.1016/j.jvacx.2023.100373
[13]
Watson, O.J., Barnsley, G., Toor, J., Hogan, A.B., Winskill, P. and Ghani, A.C. (2022) Global Impact of the First Year of COVID-19 Vaccination: A Mathematical Modelling Study. The Lancet Infectious Diseases, 22, 1293-1302. https://doi.org/10.1016/s1473-3099(22)00320-6
[14]
Arbel, R. and Pliskin, J. (2022) Vaccinations versus Lockdowns to Prevent COVID-19 Mortality. Vaccines, 10, Article 1347. https://doi.org/10.3390/vaccines10081347
[15]
Scobie, H.M., Johnson, A.G., Suthar, A.B., Severson, R., Alden, N.B., Balter, S., et al. (2021) Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status—13 U.S. Jurisdictions, April 4-July 17, 2021. Morbidity and Mortality Weekly Report, 70, 1284-1290. https://doi.org/10.15585/mmwr.mm7037e1
[16]
Han, Q., Zheng, B., Abakoumkin, G., Leander, N.P. and Stroebe, W. (2022) Why Some People Do Not Get Vaccinated against COVID-19: Social-Cognitive Determinants of Vaccination Behavior. Applied Psychology: Health and Well-Being, 15, 825-845. https://doi.org/10.1111/aphw.12411
[17]
Dababneh, E. and Siddique, M.S. (2023) Pericarditis. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK431080/
[18]
Al-Akchar, M., Shams, P. and Kiel, J. (2023) Acute Myocarditis. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK441847/
[19]
Nesheiwat, Z., Goyal, A. and Jagtap, M. (2023) Atrial Fibrillation. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK526072/
[20]
Diaz, G.A., Parsons, G.T., Gering, S.K., Meier, A.R., Hutchinson, I.V. and Robicsek, A. (2021) Myocarditis and Pericarditis after Vaccination for Covid-19. Journal of the American Medical Association, 326, 1210-1212. https://doi.org/10.1001/jama.2021.13443
[21]
Gautam, N., Saluja, P., Fudim, M., Jambhekar, K., Pandey, T. and Al’Aref, S. (2021) A Late Presentation of COVID-19 Vaccine-Induced Myocarditis. Cureus, 13, e17890. https://doi.org/10.7759/cureus.17890
[22]
Knudsen, B. and Prasad, V. (2023) Covid-19 Vaccine Induced Myocarditis in Young Males: A Systematic Review. European Journal of Clinical Investigation, 53, e13947. https://doi.org/10.1111/eci.13947
[23]
Kim, H.W., Jenista, E.R., Wendell, D.C., Azevedo, C.F., Campbell, M.J., Darty, S.N., et al. (2021) Patients with Acute Myocarditis Following mRNA COVID-19 Vaccination. JAMA Cardiology, 6, 1196-1201. https://doi.org/10.1001/jamacardio.2021.2828
[24]
Jabagi, M.J., Botton, J., Bertrand, M., Weill, A., Farrington, P., Zureik, M., et al. (2022) Myocardial Infarction, Stroke, and Pulmonary Embolism after BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older. Journal of the American Medical Association, 327, 80-82. https://doi.org/10.1001/jama.2021.21699
[25]
Kumar, A., Shariff, M., Bhat, V., DeSimone, C. and Deshmukh, A. (2022) Atrial Fibrillation after Vaccination for COVID-19: Analysis of the Vaccine Adverse Event Reporting System. Journal of Interventional Cardiac Electrophysiology, 65, 1-2. https://doi.org/10.1007/s10840-022-01263-4
[26]
Bousquet, J., Agache, I., Blain, H., Jutel, M., Ventura, M.T., Worm, M., et al. (2021) Management of Anaphylaxis Due to COVID-19 Vaccines in the Elderly. Allergy, 76, 2952-2964.
[27]
McLendon, K. and Sternard, B.T. (2023) Anaphylaxis. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK482124/
[28]
Ventura, M.T., Boni, E., Cecere, R., Buquicchio, R., Calogiuri, G.F., Martignago, I., et al. (2018) Importance of Hypersensitivity in Adverse Reactions to Drugs in the Elderly. Clinical and Molecular Allergy, 16, Article No. 7.
[29]
Urakawa, R., Isomura, E.T., Matsunaga, K. and Kubota, K. (2023) Multivariate Analysis of Adverse Reactions and Recipient Profiles in COVID-19 Booster Vaccinations: A Prospective Cohort Study. Vaccines, 11, Article 1513. https://doi.org/10.3390/vaccines11101513
[30]
Onisâi, M., Vlădăreanu, A., Spînu, A., Găman, M. and Bumbea, H. (2019) Idiopathic Thrombocytopenic Purpura (ITP)—New Era for an Old Disease. Romanian Journal of Internal Medicine, 57, 273-283. https://doi.org/10.2478/rjim-2019-0014
[31]
Ichhpujani, P., Parmar, U.P.S., Duggal, S. and Kumar, S. (2022) COVID-19 Vaccine-Associated Ocular Adverse Effects: An Overview. Vaccines, 10, Article 1879. https://doi.org/10.3390/vaccines10111879
[32]
Sunder, A., Saha, S., Kamath, S. and Kumar, M. (2022) Vaccine-Induced Thrombosis and Thrombocytopenia (VITT); Exploring the Unknown. Journal of Family Medicine and Primary Care, 11, 2231-2233. https://doi.org/10.4103/jfmpc.jfmpc_2259_21
[33]
Saluja, P., Amisha, F., Gautam, N. and Goraya, H. (2022) A Systematic Review of Reported Cases of Immune Thrombocytopenia after COVID-19 Vaccination. Vaccines, 10, Article 1444. https://doi.org/10.3390/vaccines10091444
[34]
Lambert, M.P. and Gernsheimer, T.B. (2017) Clinical Updates in Adult Immune Thrombocytopenia. Blood, 129, 2829-2835. https://doi.org/10.1182/blood-2017-03-754119
[35]
Aldeeb, M., Okar, L., Mahmud, S.S. and Adeli, G.A. (2022) Could Guillain-Barré Syndrome Be Triggered by COVID-19 Vaccination? Clinical Case Reports, 10, e05237. https://doi.org/10.1002/ccr3.5237
[36]
Warner, M.J., Hutchison, J. and Varacallo, M. (2023) Bell Palsy. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK482290/
[37]
Ogunjimi, O.B., Tsalamandris, G., Paladini, A., Varrassi, G. and Zis, P. (2023) Guillain-Barré Syndrome Induced by Vaccination against COVID-19: A Systematic Review and Meta-Analysis. Cureus, 15, e37578. https://doi.org/10.7759/cureus.37578
[38]
Hampton, L.M., Aggarwal, R., Evans, S.J.W. and Law, B. (2021) General Determination of Causation between Covid-19 Vaccines and Possible Adverse Events. Vaccine, 39, 1478-1480. https://doi.org/10.1016/j.vaccine.2021.01.057
[39]
Keh, R.Y.S., Scanlon, S., Datta-Nemdharry, P., Donegan, K., Cavanagh, S., Foster, M., et al. (2022) COVID-19 Vaccination and Guillain-Barré Syndrome: Analyses Using the National Immunoglobulin Database. Brain, 146, 739-748. https://doi.org/10.1093/brain/awac067
[40]
Albakri, K., Khaity, A., Atwan, H., Saleh, O., Al-Hajali, M., Cadri, S., et al. (2023) Bell’s Palsy and COVID-19 Vaccines: A Systematic Review and Meta-Analysis. Vaccines, 11, Article 236. https://doi.org/10.3390/vaccines11020236
[41]
Al Khames Aga, Q.A., Alkhaffaf, W.H., Hatem, T.H., Nassir, K.F., Batineh, Y., Dahham, A.T., et al. (2021) Safety of COVID-19 Vaccines. Journal of Medical Virology, 93, 6588-6594. https://doi.org/10.1002/jmv.27214
[42]
Lee, Y. and Huang, Y. (2021) Ocular Manifestations after Receiving COVID-19 Vaccine: A Systematic Review. Vaccines, 9, Article 1404. https://doi.org/10.3390/vaccines9121404
[43]
Chakraborty, S. and Sheth, J.U. (2022) Management of Submacular Hemorrhage Using Intravitreal Brolucizumab with Pneumatic Displacement: A Case Series. Case Reports in Ophthalmology, 13, 947-953. https://doi.org/10.1159/000527073
[44]
Vaillant, A.A., Misra, S. and Fitzgerald, B.M. (2024) Acute Transplantation Rejection. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK535410/
[45]
Park, H.S., Byun, Y., Byeon, S.H., Kim, S.S., Kim, Y.J. and Lee, C.S. (2021) Retinal Hemorrhage after Sars-Cov-2 Vaccination. Journal of Clinical Medicine, 10, Article 5705. https://doi.org/10.3390/jcm10235705
[46]
Ravichandran, S. and Natarajan, R. (2021) Corneal Graft Rejection after COVID-19 Vaccination. Indian Journal of Ophthalmology, 69, 1953-1954. https://doi.org/10.4103/ijo.ijo_1028_21
[47]
Solomon, A. and Frucht-Pery, J. (1996) Bilateral Simultaneous Corneal Graft Rejection after Influenza Vaccination. American Journal of Ophthalmology, 121, 708-709. https://doi.org/10.1016/s0002-9394(14)70638-5
[48]
Phylactou, M., Li, J.O. and Larkin, D.F.P. (2021) Characteristics of Endothelial Corneal Transplant Rejection Following Immunization with Sars-Cov-2 Messenger RNA Vaccine. British Journal of Ophthalmology, 105, 893-896. https://doi.org/10.1136/bjophthalmol-2021-319338
[49]
Chen, C., Hsieh, M., Wei, C. and Lin, C. (2023) Atrial Fibrillation after mRNA-1273 Sars-Cov-2 Vaccination: Case Report with Literature Review. Risk Management and Healthcare Policy, 16, 209-214. https://doi.org/10.2147/rmhp.s402007
[50]
Şahin Tekin, M., Şaylısoy, S. and Yorulmaz, G. (2021) Subacute Thyroiditis Following COVID-19 Vaccination in a 67-Year-Old Male Patient: A Case Report. Human Vaccines & Immunotherapeutics, 17, 4090-4092. https://doi.org/10.1080/21645515.2021.1947102
[51]
Deb, A., Abdelmalek, J., Iwuji, K. and Nugent, K. (2021) Acute Myocardial Injury Following COVID-19 Vaccination: A Case Report and Review of Current Evidence from Vaccine Adverse Events Reporting System Database. Journal of Primary Care & Community Health, 12, Article 21501327211029230. https://doi.org/10.1177/21501327211029230
[52]
Vujosevic, S., Limoli, C., Romano, S., Vitale, L., Villani, E. and Nucci, P. (2022) Retinal Vascular Occlusion and Sars-Cov-2 Vaccination. Graefe’s Archive for Clinical and Experimental Ophthalmology, 260, 3455-3464. https://doi.org/10.1007/s00417-022-05707-5
